Robot model
Mako
Mako (marketed as Mako SmartRobotics) is Stryker's surgeon-guided robotic-arm system for orthopedic joint replacement, recorded in the surgical form factor as the large-footprint, CT-based commercial-market-leader archetype of the orthopedic sub-cohort. It pairs CT-based three-dimensional pre-operative planning with intra-operative haptic boundary control, branded AccuStop, that physically constrains the saw or burr to the planned resection zone, and real-time optical bone tracking that keeps that boundary registered to the patient; the surgeon holds and guides the arm and makes every cut, so the system is AI-augmented surgeon-controlled assistance and not autonomous surgery, the same assistive class as Intuitive's da Vinci. Made by Stryker, listed on the New York Stock Exchange as SYK, founded in 1941 by Dr. Homer H. Stryker, incorporated in Michigan in 1946 and headquartered in Portage, Michigan, the platform entered Stryker through its roughly 1.65 billion dollar acquisition of MAKO Surgical at thirty dollars per share, announced September 25, 2013 and closed December 17, 2013, when MAKO's product was the RIO system cleared for partial knee and total hip. Its FDA-cleared scope has since broadened to partial and total knee, cementless total knee, total hip, a hip-revision feature, the Mako Spine System for non-cervical pedicle-screw placement cleared under 510(k) K241517 in May 2024, and the Mako Shoulder application for reverse shoulder arthroplasty cleared under 510(k) K242373 in November 2024. Per Stryker's FY2024 10-K the system is sold in more than forty-five countries with more than one million robotic Mako Total Knees and 1.5 million total Mako procedures performed cumulatively, and Stryker describes itself as one of four leading global competitors rather than asserting a specific market share; no installed-base system count appears in the 10-K, so any thousands-of-systems or market-share figure is aggregator-sourced and is not asserted here.
Mako is a surgical robot built by Stryker.
Machine-readable surfaces
- Markdown mirror: /models/stryker-mako.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/models/b3a006a0-d844-4fb4-b4d9-dd6f148c0958
- Data documentation: /data
- Form factor
- surgical
- Maturity stage
- commercial
- Lifecycle
- active
- Deployments
- 0
- ID
b3a006a0-d844-4fb4-b4d9-dd6f148c0958
Specs
- notes
- [object Object],[object Object],[object Object],[object Object],[object Object]
- specs
- Mako (Mako SmartRobotics): surgeon-guided robotic arm for orthopedic joint replacement. CT-based 3D pre-op planning + intra-op HAPTIC BOUNDARY CONTROL (AccuStop: physically constrains the saw/burr to the planned resection zone) + real-time optical bone tracking. The surgeon holds/guides the arm and makes every cut; the robot does not move or cut autonomously. Cleared procedures: partial/unicompartmental knee, total knee (Aug 2015), cementless total knee, total hip, a hip-revision feature, Mako Spine (510(k) K241517, May 2024; non-cervical pedicle-screw placement via the Q Guidance System), and Mako Shoulder 1.0 (510(k) K242373, Nov 2024; reverse shoulder arthroplasty). Sold in 45+ countries. Made by Stryker (NYSE: SYK).
- formFactor
- surgical (robotic-arm-assisted orthopedic joint replacement; surgeon-controlled + AI-augmented, NOT autonomous; large-footprint CT-based)
Supply chain
No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this model’s suppliers.
Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.
Sources (7)
- https://investors.stryker.com/press-releases/news-details/2013/Stryker-Announces-Definitive-Agreement-to-Acquire-MAKO-Surgical-Corp-for-165-Billion/default.aspx
- https://www.sec.gov/Archives/edgar/data/0000310764/000031076426000010/syk-20251231.htm
- https://investors.stryker.com/press-releases/news-details/2015/Stryker-Receives-FDA-Clearance-For-Mako-Total-Knee-Application/default.aspx
- https://www.accessdata.fda.gov/cdrh_docs/pdf24/K241517.pdf
- https://fda.innolitics.com/submissions/OR/subpart-e%E2%80%94neurological-surgical-devices/OLO/K242373
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12588732/
- https://www.stryker.com/us/en/joint-replacement/systems/Mako_SmartRobotics_Overview.html
Common questions
- What is Mako?
- Mako (marketed as Mako SmartRobotics) is Stryker's surgeon-guided robotic-arm system for orthopedic joint replacement, recorded in the surgical form factor as the large-footprint, CT-based commercial-market-leader archetype of the orthopedic sub-cohort. It pairs CT-based three-dimensional pre-operative planning with intra-operative haptic boundary control, branded AccuStop, that physically constrains the saw or burr to the planned resection zone, and real-time optical bone tracking that keeps that boundary registered to the patient; the surgeon holds and guides the arm and makes every cut, so the system is AI-augmented surgeon-controlled assistance and not autonomous surgery, the same assistive class as Intuitive's da Vinci. Made by Stryker, listed on the New York Stock Exchange as SYK, founded in 1941 by Dr. Homer H. Stryker, incorporated in Michigan in 1946 and headquartered in Portage, Michigan, the platform entered Stryker through its roughly 1.65 billion dollar acquisition of MAKO Surgical at thirty dollars per share, announced September 25, 2013 and closed December 17, 2013, when MAKO's product was the RIO system cleared for partial knee and total hip. Its FDA-cleared scope has since broadened to partial and total knee, cementless total knee, total hip, a hip-revision feature, the Mako Spine System for non-cervical pedicle-screw placement cleared under 510(k) K241517 in May 2024, and the Mako Shoulder application for reverse shoulder arthroplasty cleared under 510(k) K242373 in November 2024. Per Stryker's FY2024 10-K the system is sold in more than forty-five countries with more than one million robotic Mako Total Knees and 1.5 million total Mako procedures performed cumulatively, and Stryker describes itself as one of four leading global competitors rather than asserting a specific market share; no installed-base system count appears in the 10-K, so any thousands-of-systems or market-share figure is aggregator-sourced and is not asserted here.
- Who makes Mako?
- Mako is made by Stryker, based in Portage, Michigan, USA, founded in 1941.
- Where is Mako deployed?
- No verified deployments of Mako are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
- What is Mako's maturity stage?
- Mako is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.